Human Molecular Genetics Advance Access originally published online on September 20, 2008
Human Molecular Genetics 2008 17(24):4022-4035; doi:10.1093/hmg/ddn305
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome
1 Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan 2 Department of Neurology, Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA
* To whom correspondence should be addressed at: Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan. Tel: +81 527442446; Fax: +81 527442449; Email: ohnok{at}med.nagoya-u.ac.jp
Received May 19, 2008; Revised September 1, 2008; Accepted September 17, 2008
In humans and great apes, CHRNA1 encoding the muscle nicotinic acetylcholine receptor 
subunit carries an inframe exon P3A, the inclusion of which yields a nonfunctional subunit. In muscle, the P3A(–) and P3A(+) transcripts are generated in a 1:1 ratio but the functional significance and regulation of the alternative splicing remain elusive. An intronic mutation (IVS3-8G>A), identified in a patient with congenital myasthenic syndrome, disrupts an intronic splicing silencer (ISS) and results in exclusive inclusion of the downstream P3A exon. We found that the ISS-binding splicing trans-factor was heterogeneous nuclear ribonucleoprotein (hnRNP) H and the mutation attenuated the affinity of hnRNP for the ISS 
100-fold. We next showed that direct placement of hnRNP H to the 3' end of intron 3 silences, and siRNA-mediated downregulation of hnRNP H enhances recognition of exon P3A. Analysis of the human genome suggested that the hnRNPH-binding UGGG motif is overrepresented close to the 3' ends of introns. Pursuing this clue, we showed that alternative exons of GRIP1, FAS, VPS13C and NRCAM are downregulated by hnRNP H. Our findings imply that the presence of the hnRNP H-binding motif close to the 3' end of an intron is an essential but underestimated splicing regulator of the downstream exon.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Lin, P. Jiang, S. Shen, S. Sato, B. L. Davidson, and Y. Xing Large-scale analysis of exonized mammalian-wide interspersed repeats in primate genomes Hum. Mol. Genet., June 15, 2009; 18(12): 2204 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bian, A. Masuda, T. Matsuura, M. Ito, K. Okushin, A. G. Engel, and K. Ohno Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome Hum. Mol. Genet., April 1, 2009; 18(7): 1229 - 1237. [Abstract] [Full Text] [PDF]
|
|